ArticleClinical lung cancer2020

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.

Tejas Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.